ClinicalTrials.gg
RecruitingNCT06467916Updated Apr 24, 2025

The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home

An interventional study of Behavioral Treatment in Perinatal Mental Health, sponsored by University of Colorado, Denver. Recruiting at 2 sites in United States. Per ClinicalTrials.gov, last updated 2025-04-24.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Stress Disorders, Post-Traumatic by University of Colorado, Denver — 4 open to participants now, 4 under way, none of them phase 3. Stress Disorders, Post-Traumatic · University of Colorado, Denver.

Planned enrollment
6th of 12
72 · median 57
Started
2025
with 2 others
No phase
10 of 13
4 open now
Registered
11th of 13
by date

Among the 13 studies in Stress Disorders, Post-Traumatic by University of Colorado, Denver, this one is the 6th largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2025, is one of 10 with no phase, and was the 11th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

4 of the 13 studies in Stress Disorders, Post-Traumatic by University of Colorado, Denver are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Stress Disorders, Post-Traumatic by University of Colorado, Denver, or all of them as a file.
02

Study summary

The objective of this study is to develop and pilot test a telehealth-based mental health screening and engagement program that supports parents as their infants transition home from the NICU. The program will use a stepped-care approach to screen parents for depression, anxiety, and PTSD; provide a brief behavioral intervention to those who screen as having at least a low risk of these conditions; and provide a warm hand-off to community mental health services for those at medium to high risk.

03

Conditions studied

  • Perinatal Mental Health

Keywords

  • neonatal intensive care unit
  • perinatal mental health
  • perinatal depression
  • perinatal anxiety
  • posttraumatic stress disorder
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • NICU parents: Participants will be parents of currently hospitalized preterm infants from either the OHSU NICU or the UCH NICU. We will include parents of live preterm infants who have been admitted in the NICU for at least 2 weeks. Parents must speak English or Spanish. Parents can be of any age.
  • NICU stakeholders: Participants will be stakeholders from either the OHSU NICU or the UCH NICU. Stakeholders will be social workers, mental health providers responsible for providing more intensive mental health support for NICU parents, nurses, neonatologists, and hospital administrators.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Intervention

    anticipatory guidance, brief behavioral intervention, or referral to community mental health provider

    Behavioral: Behavioral Treatment

  • No intervention
    Control

    usual care

Interventions

  • BehavioralBehavioral Treatment

    anticipatory guidance, brief behavioral intervention, or referral to community mental health provider

06

What researchers measure

Primary outcomes

  1. Mental health self-efficacy scale

    Mental health self-efficacy

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

Secondary outcomes

  1. City Mental Illness Stigma Scale

    Mental illness stigma

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

  2. Parenting Sense of Self Confidence Scale

    Parenting self-efficacy

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

Other outcomes

  1. Edinburgh Postnatal Depression Scale (EDPS)

    Perinatal depression

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

  2. GAD-7

    Anxiety

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

  3. Post-Traumatic Stress Disorder Questionnaire (PPQ)

    PTSD

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Project data and materials will be administered in accordance with both participating institutional and NIH policies, including the NICH Data Sharing Policy and Implementation Guidance of March 5, 2003. Depending on such policies, materials may be transferred to others under the terms of material transfer agreement. Data, including survey instruments and datasets, will be available approximately one year after study completion. Researchers can contact the research staff to request access to datasets and support for their use. Publication of data shall occur during the project, if appropriate, or at the end of the project, consistent with normal scientific practices. The final locked dataset will be stripped of all participant identifiers. This dataset will be available to the nonprofit community for noncommercial uses provided that a data-sharing agreement is reached and that the original creators of the dataset are able to collaborate in all secondary data analysis.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: All shareable, de-identified scientific data generated from this project will be made available as soon as possible, and no later than the time of publication or the end of the funding period, whichever comes first. The duration of preservation and sharing of the data will be a minimum of 3 years after the funding period.

Access criteria: Scientific data will be findable for the research community through PubMed Central. For all publications, a digital object identifier (DOI) will be created. The data DOI will be referenced in the publication to allow the scientific community easy access to the data used in the publication.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2025; primary completion for Apr 2026, 11 months later.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 11 months is below that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2024
First posted
Jun 21, 2024
StartEst.
Apr 22, 2025
Primary completionEst.
Apr 1, 2026
CompletionEst.
Apr 30, 2026
Last update
Apr 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06467916
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Apr 22, 2025 (estimated)
Primary completion
Apr 1, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Apr 24, 2025

Study contacts

Susanne Klawetter, PhD
Contact
susanne.klawetter@cuanschutz.edu
303-724-1646
Sunah S Hwang, MD, PhD, MPH/MSPH
Contact
sunah.hwang@childrenscolorado.org
720-848-0000

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion